Allopurinol and Glomerulonephritis proliferative - a phase IV clinical study of FDA data

Summary:

Glomerulonephritis proliferative is reported as a side effect among people who take Allopurinol (allopurinol), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Famotidine, and have Hyperlipidaemia.

The phase IV clinical study analyzes which people have Glomerulonephritis proliferative when taking Allopurinol. It is created by eHealthMe based on reports of 188,106 people who have side effects when taking Allopurinol from the FDA, and is updated regularly.

What is Allopurinol?

Allopurinol has active ingredients of allopurinol. It is often used in gout. eHealthMe is studying from 190,868 Allopurinol users. Check the latest studies of Allopurinol.

What is Glomerulonephritis proliferative?

Glomerulonephritis proliferative (a disorder of the glomeruli (glomerulonephritis), or small blood vessels in the kidneys) is found to be associated with 57 drugs and 174 conditions by eHealthMe. Check the latest studies of Glomerulonephritis proliferative.

On Jul, 19, 2026

188,106 people reported to have side effects when taking Allopurinol.
Among them, 14 people (0.01%) have Glomerulonephritis proliferative.

Could Allopurinol cause Glomerulonephritis proliferative?

Among these 14 people:

How long have people been on Allopurinol when they have Glomerulonephritis proliferative? *

What is the gender of people who have Glomerulonephritis proliferative when taking Allopurinol? *

female: 35.71 %
male: 64.29 %

What is the age of people who have Glomerulonephritis proliferative when taking Allopurinol? *

What are other drugs people take besides Allopurinol? *

What are other side effects people have besides Glomerulonephritis proliferative? *

Acute Kidney Failure: 8 people, 57.14%
Erythema Multiforme (a type of hypersensitivity reaction): 4 people, 28.57%
Gastritis (inflammation of stomach): 4 people, 28.57%
High Blood Pressure: 3 people, 21.43%
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 2 people, 14.29%
Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 14.29%
Nephritis Interstitial (a kidney condition characterized by swelling in between the kidney tubules): 2 people, 14.29%
Liver Disorder (liver diseases): 2 people, 14.29%
Itching: 2 people, 14.29%
Hyperkalemia (damage to or disease of the kidney): 2 people, 14.29%

What are the existing conditions these people have? *

Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 21.43%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 21.43%
Prostate Cancer: 2 people, 14.29%
High Blood Pressure: 2 people, 14.29%
Gastritis (inflammation of stomach): 2 people, 14.29%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 7.14%
Pharyngolaryngeal Pain: 1 person, 7.14%
Parkinson's Disease: 1 person, 7.14%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 1 person, 7.14%
Bacterial Infection: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Allopurinol and have Glomerulonephritis proliferative?

- Check whether Glomerulonephritis proliferative is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Allopurinol:

Allopurinol (190,868 reports)

Browse all side effects of Allopurinol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Glomerulonephritis proliferative:

Glomerulonephritis proliferative (57 drugs)

Browse all the conditions that are associated with Glomerulonephritis proliferative:

Glomerulonephritis proliferative (174 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on allopurinol (the active ingredients of Allopurinol) and Allopurinol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.